Does holding at 10 mg for six weeks before escalating reduce vomiting?

What I have: 10 mg · six weeks · vomiting.

I suspect the usual explanation for this is wrong, or at least incomplete.

I am aware this may have a boring answer. I would still like the boring answer stated clearly.

Can someone derive this rather than assert it?

six weeks at 10 mg is 42 days at one dose level — and the arithmetic the question hides is that it also moves every dose above 10 mg back by 42 days. Whether that reduces vomiting depends on which quantity it tracks. A symptom driven by the dose itself is unchanged by waiting: 10 mg is 10 mg on day 1 and on day 42. A symptom driven by the rate of change has 42 days of no change to settle in, which is the case the hold is actually made for. The distinction is testable on your own record: plot vomiting against days-since-last-increase rather than against dose, and if the peaks line up with the increases the hold is doing something. Escalation schedules are set by a prescriber, and nothing here is medical advice.

The relevant arithmetic is that steady state takes four to five half-lives, so a one-week half-life means a four-week step interval and nothing shorter is informative.

The dose that produces an acceptable result with acceptable tolerability is the endpoint, not the top of the schedule. A substantial fraction of trial participants did well below the maximum.

In practice, holding a step for eight weeks instead of four is a legitimate approach with no efficacy cost at the destination, and it is what the trials effectively did for anyone who tolerated poorly.

Titration schedules in the licensed products were designed specifically to manage gastrointestinal tolerability, and that intent is stated in the clinical development literature.

Faster titration does not reach the destination sooner in any way that matters; it reaches the symptoms sooner.

Four half-lives between steps, minimum. Work it out for your agent.

edited 3 Aug 2026 by aine_mulcahy — removed a claim I could not source

The short version: four-weekly steps for the weekly agents, hold rather than escalate when symptoms are active, and slower is always available.

For an agent with a one-week half-life, steady state after a dose change is reached in about four to five weeks. Escalating at two weeks means escalating from a position you have not yet reached, and the resulting exposure is higher than the schedule intends.

Titrating downward is available too. Stepping back and holding is a normal adjustment rather than a failure.

A schedule described here is a published schedule for a licensed product and is not a recommendation.

Hold rather than escalate while symptoms are active. Always.